Platform updates, partnerships, regulatory milestones, and clinical evidence.
2026-05-28
Vitruvian Shield has completed an independent clinical KOL validation through Instituto Pedro Nunes under the IPN healthproof framework. The validation, finalised on 28 May 2026 as a 14-page report version Final v1.0, concludes that the platform is a clinically valuable and strategically promising platform for decentralized and hybrid clinical research.
